American Century Companies Inc Innoviva, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

A detailed history of American Century Companies Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,053,520 shares of INVA stock, worth $18.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,053,520
Previous 459,690 129.18%
Holding current value
$18.8 Million
Previous $7.54 Million 169.73%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$16.33 - $20.04 $9.7 Million - $11.9 Million
593,830 Added 129.18%
1,053,520 $20.3 Million
Q2 2024

Aug 07, 2024
BUY
$14.4 - $16.4 $5.21 Million - $5.93 Million
361,797 Added 369.58%
459,690 $7.54 Million
Q1 2024

May 14, 2024
BUY
$14.56 - $16.78 $264,074 - $304,338
18,137 Added 22.74%
97,893 $1.49 Million
Q4 2023

Feb 13, 2024
BUY
$12.32 - $16.27 $982,593 - $1.3 Million
79,756 New
79,756 $1.28 Million
Q3 2023

Nov 13, 2023
SELL
$12.37 - $13.89 $703,382 - $789,813
-56,862 Reduced 6.89%
768,059 $9.98 Million
Q2 2023

Aug 14, 2023
SELL
$11.39 - $13.72 $299,055 - $360,232
-26,256 Reduced 3.08%
824,921 $10.5 Million
Q1 2023

May 11, 2023
BUY
$10.73 - $13.6 $1.49 Million - $1.89 Million
139,241 Added 19.56%
851,177 $9.58 Million
Q4 2022

Feb 13, 2023
BUY
$11.8 - $13.78 $1.94 Million - $2.26 Million
164,118 Added 29.96%
711,936 $9.43 Million
Q3 2022

Nov 14, 2022
SELL
$11.61 - $15.22 $96,293 - $126,234
-8,294 Reduced 1.49%
547,818 $6.36 Million
Q2 2022

Aug 12, 2022
BUY
$14.32 - $19.88 $1.98 Million - $2.76 Million
138,590 Added 33.19%
556,112 $8.21 Million
Q1 2022

May 11, 2022
BUY
$15.39 - $20.25 $1.89 Million - $2.49 Million
123,095 Added 41.81%
417,522 $8.08 Million
Q4 2021

Feb 07, 2022
BUY
$15.91 - $18.72 $1.64 Million - $1.93 Million
102,910 Added 53.73%
294,427 $5.08 Million
Q3 2021

Nov 10, 2021
BUY
$13.06 - $17.24 $576,220 - $760,646
44,121 Added 29.93%
191,517 $3.2 Million
Q2 2021

Aug 05, 2021
BUY
$11.45 - $13.96 $273,689 - $333,685
23,903 Added 19.36%
147,396 $1.98 Million
Q1 2021

May 14, 2021
SELL
$11.06 - $12.87 $337,584 - $392,831
-30,523 Reduced 19.82%
123,493 $1.48 Million
Q4 2020

Feb 12, 2021
BUY
$9.33 - $12.48 $107,099 - $143,257
11,479 Added 8.05%
154,016 $1.91 Million
Q3 2020

Nov 13, 2020
BUY
$10.33 - $14.49 $65,099 - $91,315
6,302 Added 4.63%
142,537 $1.49 Million
Q2 2020

Aug 13, 2020
SELL
$11.49 - $15.26 $352,708 - $468,436
-30,697 Reduced 18.39%
136,235 $1.91 Million
Q1 2020

May 14, 2020
BUY
$8.11 - $15.23 $1.35 Million - $2.54 Million
166,932 New
166,932 $1.96 Million
Q4 2019

Feb 12, 2020
SELL
$10.28 - $14.38 $2.11 Million - $2.95 Million
-205,386 Closed
0 $0
Q3 2019

Nov 13, 2019
SELL
$10.05 - $14.55 $907,846 - $1.31 Million
-90,333 Reduced 30.55%
205,386 $2.17 Million
Q2 2019

Aug 14, 2019
BUY
$13.1 - $14.95 $944,510 - $1.08 Million
72,100 Added 32.24%
295,719 $4.31 Million
Q1 2019

May 14, 2019
BUY
$13.69 - $20.06 $135,106 - $197,972
9,869 Added 4.62%
223,619 $0
Q4 2018

Feb 13, 2019
SELL
$13.96 - $18.26 $9,464 - $12,380
-678 Reduced 0.32%
213,750 $3.73 Million
Q3 2018

Nov 02, 2018
SELL
$13.63 - $15.7 $1.17 Million - $1.35 Million
-85,783 Reduced 28.57%
214,428 $3.27 Million
Q2 2018

Aug 08, 2018
SELL
$13.44 - $17.59 $3.68 Million - $4.82 Million
-273,965 Reduced 47.71%
300,211 $4.14 Million
Q1 2018

May 03, 2018
BUY
$13.8 - $16.99 $37,867 - $46,620
2,744 Added 0.48%
574,176 $9.57 Million
Q4 2017

Feb 02, 2018
SELL
$11.73 - $14.75 $181,721 - $228,507
-15,492 Reduced 2.64%
571,432 $8.11 Million
Q3 2017

Nov 01, 2017
BUY
$12.06 - $14.12 $7.08 Million - $8.29 Million
586,924
586,924 $8.29 Million

Others Institutions Holding INVA

# of Institutions
227
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email